List of Tables
    Table 1. Muscle Relaxants Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Muscle Relaxants Drugs Market Trends
    Table 3. Muscle Relaxants Drugs Market Drivers
    Table 4. Muscle Relaxants Drugs Market Challenges
    Table 5. Muscle Relaxants Drugs Market Restraints
    Table 6. Global Muscle Relaxants Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Muscle Relaxants Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Muscle Relaxants Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Muscle Relaxants Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Muscle Relaxants Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Muscle Relaxants Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Muscle Relaxants Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Muscle Relaxants Drugs Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Muscle Relaxants Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Muscle Relaxants Drugs Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Muscle Relaxants Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Muscle Relaxants Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxants Drugs as of 2021)
    Table 18. Top Players of Muscle Relaxants Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Muscle Relaxants Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Muscle Relaxants Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Muscle Relaxants Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Muscle Relaxants Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Muscle Relaxants Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Muscle Relaxants Drugs Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Muscle Relaxants Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Muscle Relaxants Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Muscle Relaxants Drugs Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Muscle Relaxants Drugs Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Muscle Relaxants Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Muscle Relaxants Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Muscle Relaxants Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Muscle Relaxants Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Muscle Relaxants Drugs Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Muscle Relaxants Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Muscle Relaxants Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Muscle Relaxants Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Muscle Relaxants Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Muscle Relaxants Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Muscle Relaxants Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Muscle Relaxants Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Laboratories Corporation Information
    Table 43. Abbott Laboratories Description and Business Overview
    Table 44. Abbott Laboratories Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Abbott Laboratories Muscle Relaxants Drugs Product
    Table 46. Abbott Laboratories Recent Development
    Table 47. Mallinckrodt Corporation Information
    Table 48. Mallinckrodt Description and Business Overview
    Table 49. Mallinckrodt Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Mallinckrodt Product
    Table 51. Mallinckrodt Recent Development
    Table 52. Medtronic Neuromodulation Corporation Information
    Table 53. Medtronic Neuromodulation Description and Business Overview
    Table 54. Medtronic Neuromodulation Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Medtronic Neuromodulation Product
    Table 56. Medtronic Neuromodulation Recent Development
    Table 57. Vertical Pharmaceuticals Corporation Information
    Table 58. Vertical Pharmaceuticals Description and Business Overview
    Table 59. Vertical Pharmaceuticals Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Vertical Pharmaceuticals Product
    Table 61. Vertical Pharmaceuticals Recent Development
    Table 62. Johnson & Johnson Corporation Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. Par Sterile Products Corporation Information
    Table 68. Par Sterile Products Description and Business Overview
    Table 69. Par Sterile Products Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Par Sterile Products Product
    Table 71. Par Sterile Products Recent Development
    Table 72. Endo Pharmaceuticals Corporation Information
    Table 73. Endo Pharmaceuticals Description and Business Overview
    Table 74. Endo Pharmaceuticals Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Endo Pharmaceuticals Product
    Table 76. Endo Pharmaceuticals Recent Development
    Table 77. Sterimax Corporation Information
    Table 78. Sterimax Description and Business Overview
    Table 79. Sterimax Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Sterimax Product
    Table 81. Sterimax Recent Development
    Table 82. Upsher Smith Laboratories Corporation Information
    Table 83. Upsher Smith Laboratories Description and Business Overview
    Table 84. Upsher Smith Laboratories Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Upsher Smith Laboratories Product
    Table 86. Upsher Smith Laboratories Recent Development
    Table 87. Orient Pharma Corporation Information
    Table 88. Orient Pharma Description and Business Overview
    Table 89. Orient Pharma Muscle Relaxants Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Orient Pharma Product
    Table 91. Orient Pharma Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Muscle Relaxants Drugs Customers List
    Table 95. Muscle Relaxants Drugs Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Muscle Relaxants Drugs Product Picture
    Figure 2. Global Muscle Relaxants Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Muscle Relaxants Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Muscle Relaxants Drugs Sales 2017-2028 (MT)
    Figure 5. United States Muscle Relaxants Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Muscle Relaxants Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Muscle Relaxants Drugs Sales 2017-2028 (MT)
    Figure 8. United States Muscle Relaxants Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Muscle Relaxants Drugs Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Muscle Relaxants Drugs Report Years Considered
    Figure 11. Product Picture of Facial Muscle Relaxant
    Figure 12. Product Picture of Skeletal Muscle Relaxant
    Figure 13. Product Picture of Neuromuscular Relaxant
    Figure 14. Global Muscle Relaxants Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Muscle Relaxants Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Muscle Relaxants Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Muscle Relaxants Drugs Sales by Type (2017-2028) & (MT)
    Figure 18. Global Muscle Relaxants Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Muscle Relaxants Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Muscle Relaxants Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Muscle Relaxants Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Muscle Relaxants Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Muscle Relaxants Drugs Sales by Type (2017-2028) & (MT)
    Figure 24. United States Muscle Relaxants Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Muscle Relaxants Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Drug Stores
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Online Stores
    Figure 30. Global Muscle Relaxants Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Muscle Relaxants Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Muscle Relaxants Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Muscle Relaxants Drugs Sales by Application (2017-2028) & (MT)
    Figure 34. Global Muscle Relaxants Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Muscle Relaxants Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 36. United States Muscle Relaxants Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Muscle Relaxants Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Muscle Relaxants Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Muscle Relaxants Drugs Sales by Application (2017-2028) & (MT)
    Figure 40. United States Muscle Relaxants Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Muscle Relaxants Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 42. North America Muscle Relaxants Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 43. North America Muscle Relaxants Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Muscle Relaxants Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 47. Europe Muscle Relaxants Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Muscle Relaxants Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 54. Asia-Pacific Muscle Relaxants Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Muscle Relaxants Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 66. Latin America Muscle Relaxants Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Muscle Relaxants Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 71. Middle East & Africa Muscle Relaxants Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Muscle Relaxants Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Muscle Relaxants Drugs Value Chain
    Figure 76. Muscle Relaxants Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed